Booth 3042

At IFT First, PLT Health Solutions will be showcasing its portfolio of beverage-friendly functional ingredients. PLT markets more than a dozen water-dispersible and water-soluble solutions for foods and beverages. This year, PLT will place a special focus on its solutions in the energy, stress/mood, sports nutrition, and weight management categories.

The company will showcase a coconut-based Tropical Island beverage featuring Zembrin, an ingredient formulated to support stress reduction in minutes. A Mango Tango beverage will feature Zynamite S, a non-stimulant ingredient formulated for a lift in energy and mood. Summer Berry will feature PLT’s Rhodiolife Rhodiola rosea, offering adaptogenic stress relief and balance. Watermelon will feature cellflo6 for endurance, recovery, blood flow, and energy. An Isn’t Life Grape beverage will include MegaNatural-BP for next-generation cardiovascular support, and a protein infused RTD will feature Supresa Crave Control for brands seeking to support healthy eating behaviors and weight management trends adjacent to the GLP-1 category.

Consumers’ experience is becoming much more important in the beverage sector, said Steve Fink, PLT’s vice president of marketing. “Efficacy will always be the foundation when ti comes to science-backed ingredients,” said Fink. “But today’s consumers expect more than just results; they’re looking for products that align with their values and deliver a complete experience. That includes clean sourcing, traceability, and certifications, but also faster effects, enjoyable delivery formats, and standout packaging. In many ways, the experience of a product has become just as important as the science behind it. At IFT, we want the food and beverage industry to visit our booth, sample our ingredients, and feel the science. Many of these ingredients are experiential and can be felt by consumers within minutes or hours, making them particularly well-suited for beverage applications.”

Fink will be giving a presentation on PLT’s energy beverage ingredient portfolio, “New Horizons in Energy Beverages: Formulating for the Moment,” on Tuesday, July 14 at 2:30 p.m.

Energy

PLT offers zumXR extended release caffeine and Zynamite S for physical and mental energy. Cellflo6 is currently featured in a range of energy drink formulations, including a 7-Eleven branded energy beverage called 7-Select Fusion Energy.

Sports Nutrition

PLT’s beverage-friendly sports nutrition portfolio includes MegaNatural-BP grape seed extract and cellflo6 for enhanced blood flow and endurance, as well as RipFactor Muscle Accelerator, which is shown to deliver muscle strength and endurance benefits.

Weight Management

PLT’s weight management portfolio includes Slendacor Weight Management Complex and Supresa Crave Control. Slendacor has ben the subject of multiple clinical studies showing support for weight loss, non-stimulant calorie burning, and body shaping benefits. Supresa has been shown to help people resist the urge to snack. Slendacor, along with MegaNatural-BP, also demonstrate cardiometabolic benefits, the company reported.

Stress/Mood

For stress, mood, and cognitive health, PLT will be showcasing Rhodiolife Rhodiola rosea and Zembrin Sceletium tortuosum, the latter of which supports stress reductions and mood in less than two hours post-ingestion.

PLT has been engaged in an across-the-board campaign to create or modify its ingredients to make them formulation-friendly in new delivery systems, Fink noted. “Beverages present a range of challenges when it comes to consumer sensory and experience. This is especially true when it comes to plant-based and botanical ingredients. In approaching our ingredient development work, we’ve focused on things beverage producers want: uniform particle size and density, good water dispersibility/solubility, neutral taste and color and stability. At the same time, our beverage-friendly ingredients maintain features that every product developer wants: they are fast-acting to the point of being experiential, they are low dose and, maybe most importantly, they are backed by quality clinical science.”